Quote:

---

Analytical Performance – Data will be presented from studies conducted at Becton Dickinson (BD) in 2013 and 2014 that form the basis of the current analytical performance package. The data, standard operating procedures (SOPs) and other proprietary assay parameters will facilitate transfer of the assay into our prospective partner’s laboratory for the purpose of commercialization under CLIA, a process BD has executed with our target partner several times. In this poster, we will also take into account scientific advancements in the field that underscore the analytical validity of cell cycle measurements for Alzheimer’s disease, most notably stage-independence of cell cycle and relationship between cell cycle, tau tangles and amyloid depositions;

---